Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma

Walker, 1983, Projections of asbestos-related disease 1980-2009, J Occup Med, 25, 409 Connelly, 1987, Demographic patterns for mesothelioma in the United States, J Natl Cancer Inst, 78, 1053 Rice, 1994, Aggressive multimodality therapy for malignant pleural mesothelioma, Ann Thorac Surg, 58, 24, 10.1016/0003-4975(94)91066-9 Rusch, 1996, The importance of surgical staging in the treatment of malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 111, 815, 10.1016/S0022-5223(96)70342-2 Sugarbaker, 1999, Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients, J Thorac Cardiovasc Surg, 117, 54, 10.1016/S0022-5223(99)70469-1 Patz, 1992, Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability, AJR Am J Roentgenol, 159, 961, 10.2214/ajr.159.5.1414807 Bénard, 1998, Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography, Chest, 114, 713, 10.1378/chest.114.3.713 Rusch, 1988, The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 96, 171, 10.1016/S0022-5223(19)35312-7 Pass, 1998, Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma, J Thorac Cardiovasc Surg, 115, 310, 10.1016/S0022-5223(98)70274-0 Block, 1997, Improvement in staging of esophageal cancer with the addition of positron emission tomography, Ann Thorac Surg, 64, 770, 10.1016/S0003-4975(97)00619-X Graeber, 1999, Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease, J Thorac Cardiovasc Surg, 117, 719, 10.1016/S0022-5223(99)70292-8 Lowe, 1998, Positron emission tomography in lung cancer, Ann Thorac Surg, 65, 1821, 10.1016/S0003-4975(98)00106-4 Blend, 1996, New methods for the staging of colorectal cancer using noninvasive techniques, Semin Surg Oncol, 12, 253, 10.1002/(SICI)1098-2388(199607/08)12:4<253::AID-SSU4>3.0.CO;2-4 Silverman, 1998, Evaluating tumor biology and oncological disease with positron-emission tomography, Semin Radiat Oncol, 8, 183, 10.1016/S1053-4296(98)80044-1 Zasadny, 1993, Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D -glucose: variations with body weight and a method for correction, Radiology, 189, 847, 10.1148/radiology.189.3.8234714 Rusch, 1995, A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group, Chest, 108, 1122, 10.1378/chest.108.4.1122 Butchart, 1976, Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients, Thorax, 31, 15, 10.1136/thx.31.1.15 Patz, 1993, Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning, Radiology, 188, 487, 10.1148/radiology.188.2.8327702